News

US judge denies injunction, restricts copies of weight-loss drug Ozempic
A US judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and ...
News-Medical.Net on MSN6h
What’s behind Gen Z’s skepticism about Ozempic and Wegovy
A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...
Ozempic copies restricted after US judge denies injunction
A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...
Ozempic copies restricted after US judge deni
April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...
‘Game changer’: Teens using GLP-1 drugs losing weight, but long-term effects unknown
Popular drugs for weight loss are being prescribed to kids as young as 12. [DOWNLOAD: Free WSB-TV News app for alerts as news ...
Healio2h
Semaglutide adverse events named in nearly 25,000 ED visits in 2 years since approval
An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...
Zacks Investment Research on MSN17h
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...
BlackDoctor.org14h
Non-Surgical Weight Loss Treatments That Could Transform Your Body
Non-surgical weight loss treatments are becoming more accessible, effective, and more in tune with your body's natural ...